Comprehensive mapping of immune perturbations associated with severe COVID-19
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Profound plasmablast expansion, innate cell modulation, and T cell activation are defining features of severe COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We believe that the features described herein may help to identify the immunopathology of similar illnesses, such as irAEs and CRS due to other immunotherapies (e.g. checkpoint inhibitors, CAR-T-cells) or COVID-19 [4, 18, 19], and to inform discussions on the type and length of clinical and immune monitoring warranted in such patients.”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical–pathologic correlation in these individuals resulted in valuable observations that may be instructive in understanding mechanisms of immune-induced pathologies, including those of checkpoint inhibitors, CAR-T cells, and infections such as COVID-19, known to target mucosal tissues and cause severe CRS [1, 5, 8, 18, 19].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“suggesting the lung as a source for the elevated plasma levels of type I IFNs early on infection”
From COVID-19 and the human innate immune system (2021) · cites this paper as Kuri-Cervantes et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ineffective IFN innate immunity has been strongly associated with failure to control a primary SARS-CoV-2 infection and a high risk of fatal COVID-19, accompanied by innate cell immunopathology and a plasma cytokine signature of elevated CXCL10, interleukin (IL)-6, and IL-8 in many studies (Aid et al., 2020; Kuri-Cervantes et al., 2020; Li et al., 2020b; Lucas et al., 2020; Radermecker et al., 202”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Kuri-Cervantes et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“particularly observation of elevated frequencies of neutrophils (the most common cell type of the innate immune system) in blood (Kuri-Cervantes et al., 2020), and massive numbers of neutrophils in lungs, associated with severe, end-stage COVID-19 disease (Li et al., 2020b; Liao et al., 2020; Radermecker et al., 2020; Schurink et al., 2020). In contrast, end-stage disease is not generally”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Kuri-Cervantes et al., 2020
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 161
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,296
Binary Codes capable of currecting deletions, insertions, and reversals
Levenshtein, V. I. (1965) · Soviet physics. Doklady · Cited by 14,807
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Research works printed but not linked: 2
- WHO Novel Coronavirus 2019 Reports (World Health Organization 2020) vol. 2020.
- 10.1146/annurev.iy.13.040195.001015 · doi:10.1146/annurev.iy.13.040195.001015 · Paper page
Cited by
Items 201–300 of 761
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistencePreprint
Talla, A., Vasaikar, S. V., Lemos, M. P., Moodie, Z., Pebworth, M.-P., Henderson, K. E., Cohen, K. W., Czartoski, J., Lai, L., Suthar, M. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.26.442666 · Cited by 48
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Prasanna, P. G. S., Woloschak, G. E., DiCarlo, A. L., Buchsbaum, J. C., Schaue, D., Chakravarti, A., Cucinotta, F. A., Formenti, S. C., Guha, C., Hu, D. J., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00211.1 · Cited by 45
Immunity to SARS-CoV-2: Lessons Learned
FERGIE, J. E., & Srivastava, A. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654165 · Cited by 50
Sandberg, J. T., Varnaitė, R., Christ, W., Chen, P., Muvva, J. R., Maleki, K. T., García, M., Dzidic, M., Folkesson, E., Skagerberg, M., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1306 · Cited by 52
Pahl, M. C., Coz, C. L., Su, C., Sharma, P. K., Thomas, R. M., Pippin, J. A., Cabrera, E. C., Johnson, M. E., Leonard, M. E., Lu, S., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02691-1 · Cited by 46
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus
Zhou, P., Chen, J., He, J., Zheng, T., Yunis, J., Makota, F. V., Alexandre, Y. O., Gong, F., Zhang, X., Xie, W., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009858 · Cited by 48
Popescu, I., Snyder, M. E., Iasella, C. J., Hannan, S. J., Koshy, R., Burke, R., Das, A., Brown, M. J., Lyons, E. J., Lieber, S. C., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202111-2493oc · Cited by 50
Dhawan, M. K., Rabaan, A. A., Fawarah, M. M., Almuthree, S. A., Alsubki, R. A., Alfaraj, A. H., Mashraqi, M. M., Alshamrani, S., Abduljabbar, W. A., Alwashmi, A. S. S., et al. (2023) · Vaccines · doi:10.3390/vaccines11010101 · Cited by 46
COVID-19: Relationship and Impact on Breastfeeding—A Systematic Review
Pérez-Bermejo, M., Peris-Ochando, B., & Murillo-Llorente, M. T. (2021) · Nutrients · doi:10.3390/nu13092972 · Cited by 55
Immune2vec: Embedding B/T Cell Receptor Sequences in ℝN Using Natural Language Processing
Ostrovsky-Berman, M., Frankel, B., Polak, P., & Yaari, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680687 · Cited by 47
Mukund, K., Nayak, P., Ashokkumar, C., Rao, S., Almeda, J. L., Betancourt-Garcia, M. M., Sindhi, R. K., & Subramaniam, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738073 · Cited by 48
Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
Zafarani, A., Razizadeh, M. H., Pashangzadeh, S., Amirzargar, M. R., Taghavi-Farahabadi, M., & Mahmoudi, M. (2023) · Future Virology · doi:10.2217/fvl-2022-0040 · Cited by 49
Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection
Georgakopoulou, V., Makrodimitri, S., Triantafyllou, M., Samara, S., Voutsinas, P., Anastasopoulou, A. N., Papageorgiou, C. V., Spandidos, D. A., Gkoufa, A., Papalexis, P., et al. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12733 · Cited by 43
Early human B cell signatures of the primary antibody response to mRNA vaccination
Kardava, L., Rachmaninoff, N., Lau, W. W., Buckner, C. M., Trihemasava, K., de Assis, F. L., Wang, W., Zhang, X., Wang, Y., Chiang, C.-I., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204607119 · Cited by 44
Hope, J. L., & Bradley, L. M. (2021) · Science · doi:10.1126/science.abf6446 · Cited by 44
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
Yang, Y., & Iwasaki, A. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00590-x · Cited by 46
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106980 · Cited by 44
Mucosal-associated invariant T cell responses differ by sex in COVID-19
Chen, Y., Littleton, S., Giroux, N. S., Mathew, R., Ding, S., Kalnitsky, J., Yang, Y., Petzold, E., Chung, H. A., Rivera, G. O., et al. (2021) · Med · doi:10.1016/j.medj.2021.04.008 · Cited by 45
Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection
Wang, X., Xu, G., Liu, X., Liu, Y., Zhang, S., & Zhang, Z. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00754-0 · Cited by 46
Cell specific peripheral immune responses predict survival in critical COVID-19 patients
Amrute, J., Perry, A. M., Anand, G., Cruchaga, C., Hock, K. G., Farnsworth, C. W., Randolph, G. J., Lavine, K. J., & Steed, A. L. (2022) · Nature Communications · doi:10.1038/s41467-022-28505-3 · Cited by 48
The role of interleukin-22 in lung health and its therapeutic potential for COVID-19
Fang, S., Ju, D., Lin, Y. Q., & Chen, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951107 · Cited by 44
Immune memory in convalescent patients with asymptomatic or mild COVID-19
Long, Q., Jia, Y., Wang, X., Deng, H., Cao, X., Yuan, J., Fang, L., Cheng, X.-R., Luo, C., He, A.-R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00250-9 · Cited by 42
Musso, G., Taliano, C., Molinaro, F., Fonti, C., Veliaj, D., Torti, D., Paschetta, E., Castagna, E., Carbone, G., Laudari, L., et al. (2022) · Critical Care · doi:10.1186/s13054-022-03937-x · Cited by 41
High-dimensional single-cell analysis reveals the immune characteristics of COVID-19
Shi, W., Liu, X., Cao, Q., Ma, P., Le, W., Xie, L., Ye, J., Wen, W., Tang, H., Su, W., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2020 · Cited by 45
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
Alunno, A., Najm, A., Machado, P., Bertheussen, H., Burmester, G. R., Carubbi, F., Marco, G. D., Giacomelli, R., Hermine, O., Isaacs, J. D., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219724 · Cited by 42
Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19
Hoehn, K. B., Ramanathan, P., Unterman, A., Sumida, T. S., Asashima, H., Hafler, D. A., Kaminski, N., Cruz, C. S. D., Sealfon, S. C., Bukreyev, A. A., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100135 · Cited by 42
Zhou, M., Yin, Z., Xu, J., Wang, S., Liao, T., Wang, K., Li, Y., Yang, F., Wang, Z., Yang, G., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab181 · Cited by 39
“Two recent studies reported that the levels of immune cells, including neutrophils, monocytes, NK cells, and B and T lymphocytes, returned to nearly baseline levels in recovered untreated COVID-19 individuals[8, 9].”
BackgroundResultImmuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
Olwenyi, O. A., Dyavar, S. R., Acharya, A., Podany, A. T., Fletcher, C. V., Ng, C. L., Reid, S. P., & Byrareddy, S. N. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01961-4 · Cited by 45
How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
Kumar, V. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1840567 · Cited by 42
Siemińska, I., Węglarczyk, K., Surmiak, M., Kurowska-Baran, D., Sanak, M., Siedlar, M., & Baran, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.748097 · Cited by 41
Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients
Caldrer, S., Mazzi, C., Bernardi, M., Prato, M. G., Ronzoni, N., Rodari, P., Angheben, A., Piubelli, C., & Tiberti, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.789735 · Cited by 45
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19
Lenti, M. V., Aronico, N., Pellegrino, I., Boveri, E., Giuffrida, P., de Andreis, F. B., Morbini, P., Vanelli, L., Pasini, A., Ubezio, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77945-8 · Cited by 38
Aiello, A., Fard, S. N., & Goletti, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244556 · Cited by 41
Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Meng, H., Sengupta, A., Ricciotti, E., Mrčela, A., Mathew, D., Mazaleuskaya, L. L., Ghosh, S., Brooks, T. G., Turner, A. P., Schanoski, A. S., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1440 · Cited by 38
Self-citationThe COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
Bolouri, H., Speake, C., Skibinski, D. A. G., Long, S. A., Hocking, A. M., Campbell, D., Hamerman, J. A., Malhotra, U., & Buckner, J. H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143648 · Cited by 40
Upadhyay, A. A., Viox, E. G., Hoang, T. N., Boddapati, A. K., Pino, M., Lee, M. Y.-H., Corry, J., Strongin, Z., Cowan, D. A., Beagle, E. N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37425-9 · Cited by 40
Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
Vignesh, R., Shankar, E. M., Velu, V., & Thyagarajan, S. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586781 · Cited by 39
COVID-19 Immunobiology: Lessons Learned, New Questions Arise
Kaklamanos, A., Belogiannis, K., Skendros, P., Gorgoulis, V. G., Vlachoyiannopoulos, P. G., & Tzioufas, A. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719023 · Cited by 41
Schultheiß, C., Paschold, L., Willscher, E., Simnica, D., Wöstemeier, A., Muscate, F., Wass, M., Eisenmann, S., Dutzmann, J., Keyßer, G., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103325 · Cited by 42
Higashikuni, Y., Liu, W., Obana, T., & Sata, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112081 · Cited by 41
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Shafqat, A., Shafqat, S., Alsalameh, S., Kashir, J., AlKattan, K. M., & Yaqinuddin, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835104 · Cited by 38
Zhang, W., Chua, B. Y. L., Selva, K. J., Kedzierski, Ł., Ashhurst, T. M., Haycroft, E. R., Shoffner, S. K., Hensen, L., Boyd, D. F., James, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30088-y · Cited by 44
Anderson, E. M., Li, S. H., Awofolaju, M., Eilola, T., Goodwin, E. C., Bolton, M. J., Gouma, S., Manzoni, T. B., Hicks, P. D., Goel, R. R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111496 · Cited by 37
Self-citationZhang, S., Guo, M., Wu, F., Xiong, N., Ma, Y., Wang, Z., Duan, L., Chen, L., Ouyang, H., & Jin, Y. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.08.038 · Cited by 36
A review of COVID-19 biomarkers and drug targets: resources and tools
Caruso, F. P., Scala, G., Cerulo, L., & Ceccarelli, M. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa328 · Cited by 43
Roussel, M., Ferrant, J., Reizine, F., Gallou, S. L., Dulong, J., Carl, S. H., Lesouhaitier, M., Grégoire, M., Bescher, N., Verdy, C., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100291 · Cited by 37
Transcriptome and unique cytokine microenvironment of Castleman disease
Wing, A., Xu, J. Z., Meng, W., Rosenfeld, A. M., Li, E. Y., Wertheim, G. B. W., Paessler, M. E., Bagg, A., Frank, D. M., Tan, K., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00950-3 · Cited by 37
Self-citationKudryavtsev, I. V., Arsentieva, N. A., Batsunov, O. K., Korobova, Z. R., Khamitova, I. V., Isakov, D. V., Kuznetsova, R. N., Rubinstein, A., Stanevich, O. V., Lebedeva, A. A., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb44010014 · Cited by 37
Iosef, C., Martin, C. M., Slessarev, M., Gillio‐Meina, C., Cepinskas, G., Han, V. K. M., & Fraser, D. D. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17622 · Cited by 35
Accelerated immune ageing is associated with COVID-19 disease severity
Lord, J. M., Veenith, T., Sullivan, J., Sharma‐Oates, A., Richter, A. G., Greening, N. J., McAuley, H., Evans, R. A., Moss, P. A. H., Moore, S. C., et al. (2024) · Immunity & Ageing · doi:10.1186/s12979-023-00406-z · Cited by 36
Riboflavin for women’s health and emerging microbiome strategies
Dricot, C., Erreygers, I., Cauwenberghs, E., Paz, J. D., Spacova, I., Verhoeven, V., Ahannach, S., & Lebeer, S. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00579-5 · Cited by 32
Tirelli, C., AMICI, M. D., Albrici, C., Mira, S., Nalesso, G., Re, B., Corsico, A. G., Mondoni, M., & Centanni, S. (2023) · Biology · doi:10.3390/biology12020177 · Cited by 38
Identification of SARS-CoV-2–specific immune alterations in acutely ill patients
Rébillard, R., Charabati, M., Grasmuck, C., Filali-Mouhim, A., Tastet, O., Brassard, N., Daigneault, A., Bourbonnière, L., Anand, S. P., Balthazard, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145853 · Cited by 36
Shambat, S. M., Gómez-Mejía, A., Schweizer, T. A., Huemer, M., Chang, C., Acevedo, C., Bergadà-Pijuan, J., Vulin, C., Hofmaenner, D. A., Scheier, T., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010176 · Cited by 36
New insights into MAIT cells in autoimmune diseases
Fan, Q., Nan, H., Li, Z., Li, B., Zhang, F., & Bi, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114250 · Cited by 34
Viox, E. G., Hoang, T. N., Upadhyay, A. A., Nchioua, R., Hirschenberger, M., Strongin, Z., Tharp, G. K., Pino, M., Nguyen, K., Harper, J. L., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adg0033 · Cited by 35
Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children
de Farias, E. C. F., Piva, J. P., de Mello, M. L. F. M. F., Nascimento, L. M. P. P. D., Costa, C. C., Machado, M. M. M., Rodrigues, T. D. S., Carvalho, R. D. F. P., Alves, M. C. B., Aires, L. F. Q., et al. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002865 · Cited by 32
COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus
da Costa, C. B. P., Martins, F. J., da Cunha, L. E. R., Ratcliffe, N. A., de Paula, R. C., & Castro, H. C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107220 · Cited by 32
Cell‐mediated immunity to SARS‐CoV‐2
Wang, X., & Gui, J. (2020) · Pediatric Investigation · doi:10.1002/ped4.12228 · Cited by 33
Yang, J., Zhong, M., Zhang, E., Hong, K., Yang, Q., Zhou, D., Xia, J., Chen, Y.-Q., Sun, M., Zhao, B., et al. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab014 · Cited by 35
Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19
Barnova, M., Bobčáková, A., Urdova, V., Kosturiak, R., Kapustova, L., Dobrota, D., & Jeseňák, M. (2021) · Physiological Research · doi:10.33549/physiolres.934757 · Cited by 33
Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months
Kaaijk, P., Pimentel, V. O., Emmelot, M. E., Poelen, M. C. M., Çevirgel, A., Schepp, R. M., den Hartog, G., Reukers, D. F. M., Beckers, L., van Beek, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817876 · Cited by 32
Zhong, J., Tang, Q., Liang, M., & Ai, Y. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132068 · Cited by 32
Yu, E. D., Narowski, T. M., Wang, E. W., Garrigan, E., Mateus, J., Frazier, A., Weiskopf, D., Grifoni, A., Premkumar, L., Antunes, R. D. S., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.07.012 · Cited by 37
Jiang, W., Johnson, D., Adekunle, R. O., Heather, H., Xu, W., Cong, X. S., Wu, X., Fan, H., Andersson, L., Robertson, J., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28134 · Cited by 32
Severe Acute Respiratory Syndrome Coronavirus 2
Marks, M., O’Hara, G. A., Houlihan, C. F., Bell, L. C. K., Heightman, M., & Hart, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00139-6 · Cited by 32
Müller, L., & Benedetto, S. D. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00341-z · Cited by 31
Ghodake, G. S., Shinde, S. K., Kadam, A. A., Saratale, R. G., Saratale, G. D., Syed, A., Elgorban, A. M., Marraiki, N., & Kim, D.-Y. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.112969 · Cited by 34
Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection
Islamuddin, M., Mustfa, S. A., Ullah, S. N. M. N., Omer, U., Kato, K., & Parveen, S. (2022) · Inflammation · doi:10.1007/s10753-022-01651-y · Cited by 31
Microglial Inflammatory Responses to SARS‐CoV‐2 Infection: A Comprehensive Review
Dey, R., & Bishayi, B. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01444-3 · Cited by 35
Ivanova, E. N., Shwetar, J., Devlin, J. C., Buus, T. B., Gray-Gaillard, S. L., Koide, A., Cornelius, A. R., Samanovic, M. I., Herrera, A. M., Mimitou, E. P., et al. (2021) · medRxiv · doi:10.1101/2021.04.20.21255677 · Cited by 33
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
Ahmad, T., Chaudhuri, R., Joshi, M. C., Almatroudi, A., Rahmani, A. H., & Ali, S. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.588409 · Cited by 33
Ahsan, N., Rao, R. S. P., Wilson, R. S., Punyamurtula, U., Salvato, F., Petersen, M., Ahmed, M. K., Abid, M. R., Verburgt, J. C., Kihara, D., et al. (2021) · PROTEOMICS · doi:10.1002/pmic.202000279 · Cited by 34
Long COVID: Molecular Mechanisms and Detection Techniques
Constantinescu‐Bercu, A., Lobiuc, A., Căliman-Sturdza, O. A., Oita, R. C., Iavorschi, M., Pavăl, N.-E., Șoldănescu, I., Dimian, M., & Covașă, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010408 · Cited by 32
T cell phenotypes in COVID-19 - a living review
Hanna, S. J., Codd, A. S., Gea‐Mallorquí, E., Scourfield, D. O., Richter, F. C., Ladell, K., Borsa, M., Compeer, E. B., Moon, O. R., Galloway, S. A. E., et al. (2020) · Oxford Open Immunology · doi:10.1093/oxfimm/iqaa007 · Cited by 30
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
Martín‐Sánchez, E., Garcés, J., Maia, C., Inogés, S., de Cerio, A. L.-D., Carmona-Torre, F., Marín‐Oto, M., Alegre, F., Molano, E., Fernández-Alonso, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659018 · Cited by 31
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses
Haddad, N. S., Nguyen, D. C., Kuruvilla, M. E., Morrison-Porter, A., Anam, F. A., Cashman, K. S., Ramonell, R. P., Kyu, S. Y., Saini, A. S., Cabrera-Mora, M., et al. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100011 · Cited by 29
A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children
Sananez, I., Raiden, S., Algieri, S., Uranga, M., Grisolía, N., Filippo, D., Carli, N. D., Lalla, S. D., Cairoli, H., Chiolo, M. J., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103615 · Cited by 30
Ahmadi, E., Bagherpour, Z., Zarei, E., & Omidkhoda, A. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153782 · Cited by 29
Mukhopadhyay, S., Sinha, S., & Mohapatra, S. K. (2021) · BMC Genomic Data · doi:10.1186/s12863-021-01001-1 · Cited by 29
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
Sellner, J., & Rommer, P. S. (2021) · Vaccines · doi:10.3390/vaccines9020099 · Cited by 29
Characterization of T lymphocytes in severe COVID‐19 patients
Fenoglio, D., Dentone, C., Parodi, A., Biagio, A. D., Bozzano, F. M., Vena, A., Fabbi, M., Ferrera, F., Altosole, T., Bruzzone, B. M., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27037 · Cited by 28
Histomorphological patterns of regional lymph nodes in COVID-19 lungs
Haslbauer, J. D., Matter, M. S., Stalder, A. K., & Tzankov, A. (2021) · Der Pathologe · doi:10.1007/s00292-021-00945-6 · Cited by 29
Overview of Nonhuman Primate Models of SARS-CoV-2 Infection
Trichel, A. M. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-20-000119 · Cited by 29
Cillo, A. R., Somasundaram, A., Shan, F., Cardello, C., Workman, C. J., Kitsios, G. D., Ruffin, A. T., Kunning, S. R., Lampenfeld, C., Onkar, S., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100476 · Cited by 32
Wang, X., Bai, H., Ma, J., Qin, H., Jiang, T., Mao, W., Zeng, Q., Hu, F., Teng, Y., Fan, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2022.812514 · Cited by 32
Smith, A. P., Williams, E. P., Plunkett, T. R., Selvaraj, M., Lane, L. C., Zalduondo, L., Xue, Y., Vogel, P., Channappanavar, R., Jonsson, C. B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.894534 · Cited by 29
Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients
Butler, D. L., Imberti, L., Quaresima, V., Fiorini, C., Barnett, J., Chauvin, S. D., Cheng, X., Danielson, J. J., Dobbs, K., Garabedian, E., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac062 · Cited by 30
Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis
Chan, K. R., Koh, C. W., Ng, D. H. L., Qin, S., Ooi, J. S. G., Ong, E. Z., Zhang, S. L. X., Sam, H., Kalimuddin, S., Low, J. G. H., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104472 · Cited by 33
Kaiser, R. W. J., Gold, C., Joppich, M., Loew, Q., Akhalkatsi, A., Mueller, T. T., Offensperger, F., zu Senden, A. D., Popp, O., Fina, L. D., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl1710 · Cited by 32
Manickam, C., Sugawara, S., & Reeves, R. K. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008820 · Cited by 29
Metabolic Defects of Peripheral T Cells in COVID-19 Patients
Liu, X., Zhao, J., Wang, H., Wang, W., Su, X., Liao, X., Zhang, S., Sun, J., & Zhang, Z. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100068 · Cited by 30
Patel, S., & Wadhwa, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111785 · Cited by 29
Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
Rea, I. M., & Alexander, H. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101494 · Cited by 29
Predicted coronavirus Nsp5 protease cleavage sites in the human proteome
Scott, B. M., Lacasse, V., Blom, D. G., Tonner, P. D., & Blom, N. (2022) · BMC Genomic Data · doi:10.1186/s12863-022-01044-y · Cited by 27
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Rovito, R., Augello, M., Ben-Haim, A., Bono, V., Monforte, A. D., & Marchetti, G. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912336 · Cited by 35
Role of mitochondrial stress and the NLRP3 inflammasome in lung diseases
Chen, Y., Zhang, Y., Li, N., Jiang, Z., & Li, X. (2023) · Inflammation Research · doi:10.1007/s00011-023-01712-4 · Cited by 28
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
de Assis, F. L., Hoehn, K. B., Zhang, X., Kardava, L., Smith, C. D., Merhebi, O. E., Buckner, C. M., Trihemasava, K., Wang, W., Seamon, C. A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112780 · Cited by 31
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
Kozłowski, P., Leszczyńska, A., & Ciepiela, O. (2024) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2024.100068 · Cited by 31
Immune Correlates of COVID-19 Control
Poonia, B., & Kottilil, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569611 · Cited by 26
Metadata
- Authors
- Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., Kuthuru, O., Apostolidis, S. A., Bershaw, L., Dougherty, J., Greenplate, A. R., Pattekar, A., Kim, J., Han, N., Gouma, S., Weirick, M. E., Arevalo, C. P., Bolton, M. J., Goodwin, E. C., Anderson, E. M., Hensley, S. E., Jones, T. K., Mangalmurti, N. S., Luning Prak, E. T., Wherry, E. J., Meyer, N. J., & Betts, M. R.
- Affiliations
- University of Pennsylvania (US)
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA 19104, USA.
- Children's Hospital of Philadelphia (US)
- Hospital of the University of Pennsylvania (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Kuri-Cervantes, Leticia
- Wherry, E. John
- Meyer, Nuala J.
- Betts, Michael R.
- ORCID
- Kuri-Cervantes, Leticia
- Pampena, Maria Betina
- Meng, Wenzhao
- Rosenfeld, Aaron M.
- Weisman, Ariel R.
- Agyekum, Roseline S.
- Mathew, Divij
- Baxter, Amy E.
- Vella, Laura A.
- Kuthuru, Oliva
- Apostolidis, Sokratis A.
- Bershaw, Luanne
- Dougherty, Jeanette
- Greenplate, Allison R.
- Pattekar, Ajinkya
- Kim, Justin
- Han, Nicholas
- Gouma, Sigrid
- Weirick, Madison E.
- Arevalo, Claudia P.
- Bolton, Marcus J.
- Anderson, Elizabeth M.
- Hensley, Scott E.
- Jones, Tiffanie K.
- Mangalmurti, Nilam S.
- Luning Prak, Eline T.
- Wherry, E. John
- Meyer, Nuala J.
- Betts, Michael R.
- Venue
- Science Immunology
- Published
- 2020-07-03
- Volume
- 5
- Issue
- 49
- ISSN
- 2470-9468 (ISSN-L)
- PMC
- PMC7402634
- OpenAlex
- W3042587425
- Cited by
- 723
- References
- 107
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 63 · 2023: 101 · 2022: 182 · 2021: 251 · 2020: 83
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HL137006, HL137915, AI144288, P30-CA016520, AI105343, AI115712, AI117950, AI108545, AI082630, CA210944, T32 CA009140.)
- National Institute of Allergy and Infectious Diseases (AI136660)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- severe COVID-19, SARS-CoV-2, immune perturbation, hyperinflammation, T cell activation, innate lymphoid cells, granulocytes, neutrophil-to-lymphocyte ratio, prognostic factors, organ failure
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, Female, Humans, Immunity, Innate, Immunologic Memory, Lymphocyte Activation, Male, Middle Aged, Neutrophils, Pneumonia, Viral, T-Lymphocytes, B-Lymphocyte Subsets, Cytokines, Coronavirus Infections, Lymphocyte Count, Pandemics, Clonal Selection, Antigen-Mediated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.